# Table 3 Estimated Incremental Cost-effectiveness Ratio (ICER) [\$ per-additionally-vaccinated-child] of school-located influenza vaccination program in 2015–2016 [2015 dollar value]

Vaccination location All Schools Elementary Schools Secondary Schools
SLIV b Anywhere c SLIV b Anywhere c SLIV b Anywhere c
ICER using SUBTOTAL COST: (A + B + C)
Deterministic Analysis \$85.84 \$67.17 \$85.71 \$80.53 \$86.51 \$53.40
Probabilistic Analysis a (95% PCI) \$87.95 (\$70.26, \$112.92) \$68.89 (\$53.39, \$87.24) \$86.67 (\$66.82, \$108.54) \$84.18 (\$64.20, \$118.08) \$91.38 (\$84.41, \$100.98) \$53.53 (\$45.57, \$61.71)
ICER using TOTAL COST: (A + B + C)-(D)
Deterministic Analysis \$49.03 \$41.76 \$48.90 \$46.89 \$49.70 \$36.57
Probabilistic Analysis a (95% PCI) \$50.17 (\$32.46, \$77.40) \$43.55 (\$30.14, \$61.10) \$47.98 (\$29.39, \$73.91) \$47.70 (\$29.44, \$75.90) \$54.42 (\$46.72, \$63.59) \$38.73 (\$31.79, \$47.38)
1. All cost estimates were expressed in 2015 dollar value
2. Cost components (A, B, C, D) are defined in Table 2
3. a Probabilistic model used the distributions of model parameters defined in Table 2 to perform Monte Carlo simulations to provide the mean and 95% probabilistic confidence interval (PCI) of estimates
4. b SLIV: School-located influenza vaccination
5. c “Anywhere” includes both vaccinations administered at the SLIV program and those in “practices.” “Practice” indicates the vaccinations’ administration setting other than SLIV clinics, almost always (> 95%) primary care practices [16]